Trials / Completed
CompletedNCT05583318
Living Conditions After Non-Hodgkin's Lymphoma in France
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,570 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an innovative project, allowing to study for the first time the long-term living conditions of patients after diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) from population data in France. Patients will be selected from the three specialized hematology registries in France: Côte-d'Or, Gironde and Basse-Normandie. This is also one of the first studies to look at epidemiological indicators of net survival after diagnosis of follicular lymphoma and diffuse large B-cell lymphoma, adjusted for clinical factors such as disease stage, therapeutic management, and comorbidities, apart from the standard adjustment factors of age, sex, and time of diagnosis in real life. In addition, the proportion of cured patients will be estimated. For component 1, this will be the survival analysis on the initial data. For part 2, questionnaires will be sent out followed by a follow-up if necessary one month after the mailing. There is no physical interview nor any specific biological or imaging examination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | Data from hematological malignancy registries |
| OTHER | Questionnaires | 9 questionnaires were sent out: 1. QLQ-C30 and SF-12 Quality of Life Questionnaire. 2. Oral quality of life questionnaire QLQ-OH15 3. Sexuality questionnaire SHQ-C22 4. Anxiety and depression questionnaire HADS, 5. Rosenberg Self-Esteem Questionnaire 6. RNLI Reintegration to Normal Life Questionnaire 7. Social Support Questionnaire SSQ6, 8. Socio-economic status questionnaire EPICES, 9. Complementary questionnaire collecting data on socio-professional status. |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2023-11-01
- Completion
- 2023-11-01
- First posted
- 2022-10-17
- Last updated
- 2025-07-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05583318. Inclusion in this directory is not an endorsement.